Park, Christopher Y
- NYU Grossman School of Medicine · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,788
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,788
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Park, Christopher Y as a PI. Multi-PI records show the full award amount for context.
- 5R01CA251669-03R01Contact PIAdhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1NYU Grossman School of Medicine · Pathology (NIH department code)$589.3Kaward amount
- 5R01CA245502-04R01Contact PITranslational Control of Leukemia Stem Cells - Resubmission - 1NYU Grossman School of Medicine · Pathology (NIH department code)$439.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Park, Christopher Y as a PI.
FY2023 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNYU Grossman School of Medicine
- 2013$500K Cumulative Funding
- 2013R01 Grant Holder
- 2014$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #8383
- 2023$5M Cumulative Funding